|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.5 GBX | +0.82% |
|
+4.26% | -2.78% |
| 29/02 | EARNINGS: Leeds awaiting Hemmers sale, Macfarlane ups full-year payout | AN |
| 29/02 | Oncimmune Holdings plc Provides Earnings Guidance for the Year 2024 | CI |
Oncimmune Holdings plc reported earnings results for the half year ended February 28, 2023. For the half year, the company reported sales was GBP 1.12 million. Net loss was GBP 4.06 million.
Basic loss per share from continuing operations was GBP 0.058.
| 1st Jan change | Capi. | |
|---|---|---|
| -2.78% | 23M | |
| +14.78% | 78.37B | |
| +11.98% | 9.08B | |
| -12.85% | 5.06B | |
| +54.35% | 4.85B | |
| +16.62% | 2.37B | |
| -20.85% | 2.36B | |
| +24.62% | 2.27B | |
| -29.25% | 2.22B | |
| -0.50% | 1.64B |
ONCIMMUNE HOLDINGS PLC 
